Insider Trading History of Conrad Herbert J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Conrad Herbert J since 2007. The trader's CIK number is 1218815. At the time of the last reporting, Conrad Herbert J was the Director of Matinas Biopharma Holdings, Inc.. (stock ticker symbol MTNB). Also see all insider trading activities at Matinas Biopharma Holdings, Inc..

Note that in the past CONRAD HERBERT J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Pharmasset Inc (VRUS) by Conrad Herbert J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2011 VRUS 0 $0 40,000 $3,961,600 40,000 $702,000

Yearly summary of insider trading at Matinas Biopharma Holdings, Inc. (MTNB) by Conrad Herbert J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 MTNB 25,000 $24,125 0 $0 0 $0
2017 MTNB 100,000 $130,000 0 $0 0 $0

Yearly summary of insider trading at Savient Pharmaceuticals Inc (SVNT) by Conrad Herbert J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 SVNT 0 $0 40,000 $879,629 40,000 $147,505
2007 SVNT 0 $0 30,000 $447,689 30,000 $298,838


Insider trading activities at 3 companies by Conrad Herbert J:

1. Pharmasset Inc (VRUS)

2. Matinas Biopharma Holdings, Inc. (MTNB)

3. Savient Pharmaceuticals Inc (SVNT)

Table 1. Insider trading of Pharmasset Inc (VRUS) by Conrad Herbert J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2011-05-03 VRUS Option Ex 40,000 17.55 702,000
2011-05-03 VRUS Sale 40,000 99.04 3,961,600

Table 2. Insider trading of Matinas Biopharma Holdings, Inc. (MTNB) by Conrad Herbert J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-16 MTNB Buy 25,000 .96 24,125
2017-09-07 MTNB Buy 100,000 1.30 130,000

Table 3. Insider trading of Savient Pharmaceuticals Inc (SVNT) by Conrad Herbert J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-04-02 SVNT Sale 5,000 21.11 105,570
2008-04-01 SVNT Sale 5,000 21.89 109,445
2008-04-02 SVNT Option Ex 5,000 2.48 12,400
2008-04-01 SVNT Option Ex 5,000 3.83 19,150
2008-03-04 SVNT Sale 5,000 23.00 115,000
2008-03-03 SVNT Sale 5,000 22.78 113,900
2008-03-04 SVNT Option Ex 5,000 4.61 23,050
2008-03-03 SVNT Option Ex 5,000 5.05 25,250
2008-02-01 SVNT Sale 5,000 19.30 96,515
2008-02-04 SVNT Option Ex 5,000 4.67 23,350
2008-02-04 SVNT Sale 5,000 20.00 100,000
2008-02-01 SVNT Option Ex 5,000 2.70 13,500
2008-01-02 SVNT Option Ex 5,000 2.96 14,800
2008-01-03 SVNT Option Ex 5,000 3.20 16,005
2008-01-02 SVNT Sale 5,000 23.60 118,000
2008-01-03 SVNT Sale 5,000 24.24 121,199
2007-11-28 SVNT Option Ex 2,500 11.81 29,532
2007-11-29 SVNT Option Ex 2,500 12.74 31,850
2007-11-30 SVNT Option Ex 5,000 12.74 63,700
2007-11-28 SVNT Sale 2,500 13.75 34,375
2007-11-29 SVNT Sale 2,500 14.74 36,850
2007-11-30 SVNT Sale 5,000 14.03 70,130
2007-10-10 SVNT Option Ex 5,000 11.81 59,065
2007-10-10 SVNT Sale 5,000 15.11 75,550
2007-10-09 SVNT Sale 5,000 15.12 75,585
2007-10-05 SVNT Option Ex 2,871 7.88 22,609
2007-10-05 SVNT Sale 2,871 15.52 44,557
2007-10-08 SVNT Option Ex 4,629 7.64 35,365
2007-10-09 SVNT Option Ex 5,000 7.41 37,030
2007-10-08 SVNT Sale 4,629 15.52 71,842
2007-10-03 SVNT Option Ex 2,500 7.88 19,687
2007-10-03 SVNT Sale 2,500 15.52 38,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Conrad Herbert J (Director of Matinas Biopharma Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.